Institut für Biomedizin

Deutsch

English
Italiano

Von der Klinik ins Labor und zurück zu den Patientinnen und Patienten verläuft unsere wissenschaftliche Arbeit. Wir erforschen, welchen Einfluss die genetische Veranlagung, die persönliche Umgebung und der Lebensstil auf die Entstehung und Entwicklung von Krankheiten und auf die Gesundheit der Menschen hat.

1 - 7

Institut für Biomedizin - Biomedicine Lab© Eurac Research - Ivo Corra'

Facts
& Figures

Mitarbeitende

39 mit abgeschlossenem PhD

Laufende Projekte

28 mit internationalen Partnern

Publikationen in Fachzeitschriften

Beiträge in Tagungsbänden

Labors und Facilities

Biomedicine laboratory, Biobank, Zentrum CHRIS

Data refer to the last issue of the Activity Report. See all Facts & Figures.

Research Fields

1 - 3

Molecular and Cellular Biology

“Without understanding molecules we can only have a very sketchy understanding of life itself.” F. Crick

Health Data Science

"It is easy to lie with statistics. It is hard to tell the truth without it" A. Dunkels

ELSI

"Responsible research only happens if science and ethical analysis grow together"

News & Events

1 - 10

26 May 2023

Our Research at the Human Microbiome Symposium

22 May 2023

La diffusione dell'informazione dalla Ricerca alla pratica medica, alle persone

Due eventi locali organizzati in occasione della giornata mondiale dell’ipertensione.

05 May 2023

Gesundheitsforschung: Land, Sabes und Eurac bauen Synergien aus

Mehrere Akteure betreiben Gesundheitsforschung in Südtirol. Nun wollen Land, Gesundheitsbetrieb und Eurac Research die Synergien verstärken, um so auch den Zugriff auf Forschungsgelder zu erleichtern.

02 May 2023

Kidney biomarkers and cardiovascular risk in South Tyrol population-based studies

We recently published a paper on PLOS ONE journal investigating how we can integrate routinely measured kidney biomarkers to predict cardiovascular risk over 10 years.

19 April 2023

New publication on mitochondrial dysfunction and Parkinson's disease

We identified potential presymptomatic molecular markers in clinically non-manifesting heterozygous PRKN variant carriers that could be used to monitor heterozygous PRKN variant carriers during the ...

31 March 2023

CHRIS COVID-19 study

A longitudinal analysis of a population representative sample

28 March 2023

Our new paper on Parkinson’s disease

We evaluated the neuroprotective role of a novel target against alpha-synuclein neuropathology and elucidated its role in the autophagy-lysosome pathway. We validated the potential of the small GTPase ...